Mast Cells as a Factor in Regulation of Breast Cancer Stromal Component Associated with Breast Cancer Aggressiveness
DOI:
https://doi.org/10.15407/exp-oncology.2024.04.311Keywords:
breast cancer, mast cells, collagen matrix, MMP, extracellular matrix remodelingAbstract
Background. It has been proven that changes in the morphology, representation, and organization of collagen fibers contribute to the formation of a unique microenvironment, which is associated with the metastatic potential of malignant neoplasms due to the initiation of cell migration and changes in polarization. Among the modulators of the collagen stroma, fibroblasts remain the most widely studied today. At the same time, much less attention is focused on the study of immune cells in the tumor microenvironment, in particular, mast cells (MCs). Aim. To investigate the relationship between the MCs status and the features of the collagen matrix of breast cancer (BCa). Materials and Methods. The study was conducted on the postoperative material of 78 patients with BCa stage I—II. MCs were assessed by a histochemical method using toluidine blue. For estimation of the functional activity of MCs, a degranulation index was calculated. COL1A1, COL3A1, and MMP-9 expression in tumor tissue was assessed immunohistochemically. A visualization of collagen fibers was performed using the staining by Malory. Microphotographs were pre-processed in Adobe Photoshop SS 2019 and analyzed using the software packages CurveAlign v. 4.0 and ImageJ. Results. Tumor tissue with a high density and functional activity of MCs was characterized by an increased expression of COL1A1 (p < 0.05), COL3A1 (p < 0.05), and MMP-9 (p < 0.05). In BCa tissue with the lower MCs degranulation index, collagen fibers become thicker (p < 0.05), shorter (p < 0.05), and denser (p < 0.05). At the same time, the existence of a relationship between the levels of miR-155-5p and the expression of COL1A1 (r = 0.703, p = 0.009), COL3A1 (r = 0.603, p = 0.043), and MMP-9 in tumor cells (r = 0.562, p = 0.039) and in the stroma (r = 0.546, p = 0.038), as well as the associations of the levels of this miRNA with the fiber length (r = –0.632, p = 0.013), width (r = –0.522, p = 0.048), and density (r = 0.699, p = 0.014) were found. Significantly higher rates of miR-155-5p expression (p < 0.05) were recorded in BCa tissue with a high index of MCs degranulation. Conclusion. During the BCa progression, the role of MCs in the manifestation of the tumor development increases. A growing number of infiltrated MCs contributes to the activation of MMP and fibrillar collagen expression. These changes lead to increased remodeling of the tumor stroma, which is directly reflected in the spatial organization of the collagen matrix. The increased activity of proteases causes a decrease in the length and width of fibrils, which is explained by a decrease in the number of mature fibers and their disorganization in three-dimensional space. The obtained data allow us to assert that MCs play a key role not only in the formation of a specific immune microenvironment of BCa but also in determining the direction of changes in the tumor stroma, which promotes cancer aggressiveness.
References
Tiwari A, Trivedi R, Lin SY. Tumor microenvironment: barrier or opportunity towards effective cancer therapy.
J Biomed Sci. 2022;29(1):83. https://doi.org/10.1186/s12929-022-00866-3
Lukianova N, Mushii O, Zadvornyi T, Chekhun V. Development of an algorithm for biomedical image analysis of the spatial organization of collagen in breast cancer tissue of patients with different clinical status. FEBS Open Bio. 2024;14(4):675-686. https://doi.org/10.1002/2211-5463.13773
Lukianova N, Zadvornyi T, Mushii О, et al. Evaluation of diagnostic algorithm based on collagen organization parameters for breast tumors. Exp Oncol. 2022;44(4):281-286. https://doi.org/10.32471/exp-oncology.2312-8852.vol- 44-no-4.19137
Zadvornyi T, Lukianova N, Mushii O, et al. Benign and malignant prostate neoplasms show different spatial organiza- tion of collagen. Croat Med J. 2023;64(6):413-420. https://doi.org/10.3325/cmj.2023.64.413
Naleskina LA, Lukianova NY, Zadvornyi TV, et al. Remodeling the architecture of collagen-containing connective tissue fibers of metastatic prostate cancer. Cytol Genet. 2023;57:406-412. https://doi.org/10.3103/S0095452723050031
Lukianova N, Zadvornyi Т, Borikun Т, et al. Significance of osteopontin for predicting aggressiveness of prostate cancer. Exp Oncol. 2023;45(3):312-321. https://doi.org/10.15407/exp-oncology.2023.03.312
Chekhun V, Pavlova A, Zadvornyi T, et al. Expression of SPP1 and SPARC genes in tumor tissue of patients with breast cancer. Exp Oncol. 2024;46(1):13-21. https://doi.org/10.15407/exp-oncology.2024.01.013
Chekhun V, Mushii O, Zadvornyi T, et al. Features of COL1A1 expression in breast cancer tissue of young patients.
Exp Oncol. 2023;45(3):351-363. https://doi.org/10.15407/exp-oncology.2023.03.351
Janjanam J, Pano G, Wang R, et al. Matricellular protein WISP2 is an endogenous inhibitor of collagen linearization and cancer metastasis. Cancer Res. 2021;81(22):5666-5677. https://doi.org/10.1158/0008-5472.CAN-20-3982
Simon T, Salhia B. Cancer-associated fibroblast subpopulations with diverse and dynamic roles in the tumor micro- environment. Mol Cancer Res. 2022;20(2):183-192. https://doi.org/10.1158/1541-7786.MCR-21-0282
Xu R, Yin P, Wei J, Ding Q. The role of matrix stiffness in breast cancer progression: a review. Front Oncol. 2023;13:1284926. https://doi.org/10.3389/fonc.2023.1284926
Mushii О, Pavlova А, Bazas V, et al. Osteopontin-regulated changes in the mast cell population are associated with breast cancer. Exp Oncol. 2024;46(3):209-220. https://doi.org/10.15407/exp-oncology
Yoshii M, Jikuhara A, Mori S, et al. Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners. J Pharmacol Sci. 2005;98(4):450-458. https://doi.org/10.1254/jphs.fpj05002x
Blair RJ, Meng H, Marchese MJ, et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest. 1997;99(11):2691-2700. https://doi.org/10.1172/JCI119458
Baram D, Vaday GG, Salamon P, et al. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J Immunol. 2001;167(7):4008-4016. https://doi.org/10.4049/jimmu- nol.167.7.4008
Atiakshin D, Buchwalow I, Tiemann M. Mast cells and collagen fibrillogenesis. Histochem Cell Biol. 2020;154(1):21- 40. https://doi.org/10.1007/s00418-020-01875-9
Linder DP, Poberiĭ IA, Rozkin MIa, Efimov VS. Morfometricheskiĭ analiz populiatsii tuchnykh kletok [Morphomet- ric analysis of a mast cell population]. Arkh Patol. 1980;42(6):60-64. PMID: 6998431
McClelland RA, Wilson D, Leake R, et al. A multicentre study into the reliability of steroid receptor immunocy- tochemical assay quantification. British Quality Control Group. Eur J Cancer. 1991;27(6):711-715. https://doi. org/10.1016/0277-5379(91)90171-9
Fedchenko N, Reifenrath J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue — a review. Diagn Pathol. 2014;9:221. https://doi.org/10.1186/s13000-014-0221-9
Seyed Jafari SM, Hunger RE. IHC Optical Density Score: A new practical method for quantitative immunohis- tochemistry image analysis. Appl Immunohistochem Mol Morphol. 2017;25(1):e12-e13. https://doi.org/10.1097/ PAI.0000000000000370
Chekhun V, Borikun T, Zadvornyi T, et al. Osteonectin (SPARC) prognostic value in prostate cancer. Pathol Res Pract. 2024;254:155053. https://doi.org/10.1016/j.prp.2023.155053
Zhang JD, Ruschhaupt M, Biczok R. ddCt method for qRT–PCR data analysis. Available from: https://www.biocon- ductor.org/packages/devel/bioc/vignettes/ddCt/inst/doc/rtPCR.pdf Accessed October 29, 2024
Vlachos IS, Paraskevopoulou MD, Karagkouni D, et al. DIANA-TarBase v7.0: indexing more than half a million ex- perimentally supported miRNA:mRNA interactions. Nucleic Acids Res. 2015;43:D153-D159. https://doi.org/10.1093/ nar/gku1215
Sherman BT, Hao M, Qiu J, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216-W221. https://doi.org/10.1093/nar/gkac194
Mohammed Z, McHale C, Kubinak JL, et al. miR-155 is a positive regulator of FcεRI-induced cyclooxygenase-2 expres- sion and cytokine production in mast cells. Front Allergy. 2022;3:835776. https://doi.org/10.3389/falgy.2022.835776
Csak T, Bala S, Lippai D, et al. MicroRNA-155 deficiency attenuates liver steatosis and fibrosis without reducing inflammation in a mouse model of steatohepatitis. PLoS One. 2015;10(6):e0129251. https://doi.org/10.1371/journal. pone.0129251
Chen Y, Xu D, Yao J, et al. Inhibition of miR-155-5p exerts anti-fibrotic effects in silicotic mice by regulating me- prin α. Mol Ther Nucleic Acids. 2020;19:350-360. https://doi.org/10.1016/j.omtn.2019.11.018
Lou R, Chen J, Zhou F, et al. Exosomal miRNA-155-5p from M1-polarized macrophages suppresses angiogene- sis by targeting GDF6 to interrupt diabetic wound healing. Mol Ther Nucleic Acids. 2023;34:102074. https://doi. org/10.1016/j.omtn.2023.102074
Jiang X, Shapiro DJ. The immune system and inflammation in breast cancer. Mol Cell Endocrinol. 2014;382(1):673- 682. https://doi.org/10.1016/j.mce.2013.06.003
Ortiz-Montero P, Londoño-Vallejo A, Vernot JP. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Commun Signal. 2017;15(1):17. https://doi.org/10.1186/s12964-017-0172-3
Murray JI, West NR, Murphy LC, Watson PH. Intratumoural inflammation and endocrine resistance in breast can- cer. Endocr Relat Cancer. 2015;22(1):R51-R67. https://doi.org/10.1530/ERC-14-0096
Adair-Kirk TL, Senior RM. Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol. 2008;40(6-7):1101-1110. https://doi.org/10.1016/j.biocel.2007.12.005
Kanbe N, Tanaka A, Kanbe M, et al. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol. 1999;29(8):2645-2649. https://doi.org/10.1002/(SICI)1521-4141(199908)29:08<2645::AID-IMMU2645>3.0.CO;2-1
Xu L, Cai Z, Yang F, Chen M. Activation-induced upregulation of MMP9 in mast cells is a positive feedback mediator for mast cell activation. Mol Med Rep. 2017;15(4):1759-1764. https://doi.org/10.3892/mmr.2017.6215
Hu G, Wang S, Cheng P. Tumor-infiltrating tryptase+ mast cells predict unfavorable clinical outcome in solid tu- mors. Int J Cancer. 2018;142(4):813-821. https://doi.org/10.1002/ijc.31099
Mangia A, Malfettone A, Rossi R, et al. Tissue remodelling in breast cancer: human mast cell tryptase as an ini- tiator of myofibroblast differentiation. Histopathology. 2011;58(7):1096-1106. https://doi.org/10.1111/j.1365- 2559.2011.03842.x
Abe M, Kurosawa M, Ishikawa O, et al. Mast cell tryptase stimulates both human dermal fibroblast prolifera- tion and type I collagen production. Clin Exp Allergy. 1998;28(12):1509-1517. https://doi.org/10.1046/j.1365- 2222.1998.00360.x
Yamamoto T, Hartmann K, Eckes B, Krieg T. Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interaction: role of stem cell factor/c-kit. Immunology. 2000;99(3):435-439. https://doi. org/10.1046/j.1365-2567.2000.00973.x
Behzad H, Sharma A, Mousavizadeh R, et al. Mast cells exert pro-inflammatory effects of relevance to the patho- physiology of tendinopathy. Arthritis Res Ther. 2013;15(6):R184. https://doi.org/10.1186/ar4374
Feng TY, Azar FN, Dreger SA, et al. Reciprocal interactions between the gut microbiome and mammary tissue mast cells promote metastatic dissemination of HR+ breast tumors. Cancer Immunol Res. 2022;10(11):1309-1325. https:// doi.org/10.1158/2326-6066.CIR-21-1120
Dong X, Geng Z, Zhao Y, et al. Involvement of mast cell chymase in burn wound healing in hamsters. Exp Ther Med. 2013;5(2):643-647. https://doi.org/10.3892/etm.2012.836
Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc ep- silon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med. 1994;180(6):2027-2037. https://doi.org/10.1084/jem.180.6.2027
E Ribeiro LSF, Dos Santos JN, Rocha CAG, Cury PR. Association between mast cells and collagen maturation in chro- nic periodontitis in humans. J Histochem Cytochem. 2018;66(6):467-475. https://doi.org/10.1369/0022155418765131
Partusch L, Michler JK, De Spiegelaere W. Collagen remodeling in equine exuberant granulation tissue characterized by picrosirius red staining 34th EAVA Congress, Abstracts, 2023. Available from: https://biblio.ugent.be/publication
/01HMGZGGXKHMXV3YJM1B4ZRDPP
Lukianova N, Zadvornyi T, Kashuba E, et al. Expression of markers of bone tissue remodeling in breast cancer and prostate cancer cells in vitro. Exp Oncol. 2022;44(1):39-46. https://doi.org/10.32471/exp-oncology.2312-8852.vol-44- no-1.17354
Nagasaka A, Matsue H, Matsushima H, et al. Osteopontin is produced by mast cells and affects IgE-mediated de- granulation and migration of mast cells. Eur J Immunol. 2008;38(2):489-499. https://doi.org/10.1002/eji.200737057
Tong Y, Zhou MH, Li SP, et al. MiR-155-5p attenuates vascular smooth muscle cell oxidative stress and migration via inhibiting BACH1 expression. Biomedicines. 2023;11(6):1679. https://doi.org/10.3390/biomedicines11061679
Guo P, Qiao F, Huang D, et al. MiR-155-5p plays as a "janus" in the expression of inflammatory cytokines induced by T-2 toxin. Food Chem Toxicol. 2020;140:111258. https://doi.org/10.1016/j.fct.2020.111258
Cazzanelli P, Lamoca M, Hasler J, et al. The role of miR-155-5p in inflammation and mechanical loading during intervertebral disc degeneration. Cell Commun Signal. 2024;22(1):419. https://doi.org/10.1186/s12964-024-01803-7
Kalantzakos T, Hooper K, Das S, et al. MicroRNA-155-5p targets JADE-1, promoting proliferation, migration, and in- vasion in clear cell renal cell carcinoma cells. Int J Mol Sci. 2023;24(9):7825. https://doi.org/10.3390/ijms24097825
Li Y, Zhang L, Dong Z, et al. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer. Pathol Res Pract. 2021;220:153405. https://doi.org/10.1016/j.prp.2021.153405
Wang X, Chen Y, Yuan W, et al. MicroRNA-155-5p is a key regulator of allergic inflammation, modulating the epi- thelial barrier by targeting PKIα. Cell Death Dis. 2019;10(12):884. https://doi.org/10.1038/s41419-019-2124-x
Wang Z, Yi T, Long M, et al. Involvement of the negative feedback of IL-33 signaling in the anti-inflammatory ef- fect of electro-acupuncture on allergic contact dermatitis via targeting microRNA-155 in mast cells. Inflammation. 2018;41(3):859-869. https://doi.org/10.1007/s10753-018-0740-8
Zhou X, Zhang J, Liu J, et al. MicroRNA miR-155-5p knockdown attenuates Angiostrongylus cantonensis-induced eosinophilic meningitis by downregulating MMP9 and TSLP proteins. Int J Parasitol. 2021;51(1):13-22. https://doi. org/10.1016/j.ijpara.2020.07.013
Bala S, Zhuang Y, Nagesh PT, et al. Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling.
Mol Ther Nucleic Acids. 2023; 33:413-427. https://doi.org/10.1016/j.omtn.2023.07.012
He W, Huang H, Xie Q, et al. MiR-155 knockout in fibroblasts improves cardiac remodeling by targeting tu- mor protein p53-inducible nuclear protein 1. J Cardiovasc Pharmacol Ther. 2016;21(4):423-435. https://doi. org/10.1177/1074248415616188
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
